baber/WOPTO huggingface dataset:
Patent JP-2543871-B2 (JP)
IPC: G01N33/52
Filed: 1987-03-10
Granted: 1996-10-16
Abstract: A method and device for collecting and testing fecal occult blood which permits multiple analyses of a single fecal sample. The device is a combination of a sampler for collecting the fecal matter and a test slide. The fecal sampler comprises a pocket-like wipe pad for obtaining direct anal stool smears. An insert is disposed in the pocket of the wipe pad. The slide has a profiled opening similar to the design of the wipe pad. This opening acts as a receptacle for the pad when the fecal smear is transferred to the guaiac specimen receiving sheet of the slide. When the slide is closed the insert can be removed from the wipe pad. This design permits an analysis to be done on the specimen receiving sheet of the slide together with a second confirmatory test for human hemoglobin on portions of the insert. The fecal material on the insert is physically removed from the guaiac specimen receiving sheet.
Patent JP-2986727-B2 (JP)
IPC: F41J9/02
Filed: 1996-03-21
Granted: 1999-12-06
Abstract: PROBLEM TO BE SOLVED: To provide a firing practice target arena that is based on real lives to appear in multiple modes adding animation to moving targets that include vicious criminals simulating the real lives assuming a place where people gather. SOLUTION: This firing practice target arena comprises crosswise running target devices 2 and lengthwise running target devices 4 that are generally concealed underground 1-2 and with which the selected target silhouettes 6 that are instructed by an emergence order out of the target silhouettes 6 appear to ground 1-1 when the emergence order is accepted, an instructing device 7 that sends out the emergence orders to each lengthwise and crosswise running objective device 2 and 4, rails 3 and 5 that are arranged underground to have the lengthwise and crosswise running devices 2 and 4 run in lengthwise and crosswise directions, fixtures 9 that are arranged at expected places for training and transmission means 8 to transfer the emergence orders sent out from the instructing device 7 to the lengthwise and the crosswise running devices 2 and 4.
Patent JP-H0321547-B2 (JP)
IPC: A01N43/84
Filed: 1979-06-26
Abstract: 1. A process for the preparation of a stereoisomeric N-aralkyl-2,6-dimethylmorpholine of the formula I  see diagramm : EP0007093,P5,F1  where R1  is hydrogen, an aliphatic radical of 1 to 10 carbon atoms or alkoxy of 1 to 6 carbon atoms and R2 , R3  and R4 each denote hydrogen or an aliphatic radical of 1 to 4 carbon atoms, or of a defined mixture of such compounds, by reacting a stereoisomeric 2,6-dimorpholine of the formula II  see diagramm : EP0007093,P5,F2  are defined mixture of such compounds with a compound of the formula III  see diagramm : EP0007093,P5,F3  where R1 , R2 , R3  and R4  have the above meanings, characterized in that the reaction is carried out in the presence of hydrogen and of a hydrogenation catalyst with contains palladium mixed with silver on an inert carrier.
Patent JP-H0747606-B2 (JP)
IPC: C08F2/38
Filed: 1989-04-07
Abstract: Process for the polymerisation of chloroprene in alkaline aqueous emulsion in the presence of modifying agents. According to the invention the polymerisation is conducted in the presence of at least two chain transfer agents chosen from xanthogen disulphides and bis(acylaminophenyl) polysulphides. The polymers obtained exhibit good aging and have excellent mechanical and dynamic characteristics in the vulcanised state.
Patent JP-H0735374-B2 (JP)
IPC: C07D295/08
Filed: 1991-04-19
Abstract: Process for the preparation of the compound of formula I: 
<IMAGE>
 characterised in that 2,3,4-trimethoxybenzaldehyde is dissolved, with piperazine, and the reaction mixture is then subjected to the action of hydrogen to form the compound of formula I.
Patent JP-2980936-B2 (JP)
IPC: F16H7/12
Filed: 1990-04-12
Granted: 1999-11-22
Abstract: A belt tensioner (26) suitable for use with an automotive serpentine belt system comprises a fixed structure (36) adapted to be mounted on an automotive engine, a pivoted structure (40) mounted on the fixed structure for pivotal movement relative thereto, and a torsional spring (44) connected between the fixed structure (36) and the pivoted structure (40) for resiliently biasing the pivoted structure (40) towards a maximum extension position. The torsional spring (44) is in the form of a helical coil connected between the fixed and pivoted structures, a major portion of the helical coil (44) being free from contact with the fixed and pivoted structures and therefore subject to vibration. In accordance with the invention a spring stabilizer (118) is mounted in engagement with the interior of the spring (44) for preventing or inhibiting vibration of the spring (44).
Patent JP-S6028109-B2 (JP)
IPC: H01R12/71
Filed: 1977-08-12
Abstract: 1527329 Electric terminals AMP Inc 12 July 1977 [12 Aug 1976 27 Jan 1976] 29143/77 Heading H2E An electrical terminal 1 camprises a slot 8 in a plate 2, e.g. of spring metal, the slot having a portion 14 receiving wires 28, 30 and diverging portions 18, 20 such that each wire can be moved from portion 14 into one of the portions 18, 20, the maximum width of portion 14 being less than the sum of the diameters of the wires and greater than the diameter of either wire and the maximum width of each portion 18, 20 being less than the diameter of either wire.
Patent JP-S633341-B2 (JP)
IPC: G06F7/22
Filed: 1983-06-03
Abstract: A programming method and structure for operating a computing system to restart a total subsystem or a subset of that subsystem to an operable state following a total interruptions (system failure or termination, either normal or abnormal). The subsystem isolates inoperable resources while permitting the others to resume by independently maintaining in a first structure recording the completion state of a resource manager's recovery responsibility with respect to each interrupted work unit and in a second structure the operational states and recovery log interest scopes of each resource manager. The completion state can be influenced by the starting or not of a resource manager, and if restarted, the presence or absence of a resource subset required to accomplish the work unit recovery.
Patent JP-3296363-B2 (JP)
IPC: G10L19/07
Filed: 1991-04-30
Granted: 2002-06-24
Abstract: PURPOSE:To enable high-efficiency encoding with a small calculation quantity without deteriorating quality so much. CONSTITUTION:A linear prediction parameter indicating the spectrum envelope characteristic of a voice is converted into LSP f1(k), which is quantized in stages by a multi-stage vector quantizing method with delayed decision at intervals of 40 milliseconds (m=4, 4m = frame) to obtain plural (4-8) quantization candidates fi*(k,u); and values among respective frames from each one fi*(k) and the former fi*(k-m) are estimated by a linear interpolating method from them and matrix quantization is so performed that the error between the fi*(k) and its estimated values fi*(k-l)-fi*(k-3), and the real values fi*(k)- fi*(k-3) of the respective corresponding frames become minimum. Then the quantized value Fij*(k') and distortion dmin are found and the fi*(k) and Fij*(k') which minimize dmin among the quantization candidates fi*(k,u) are regarded as an encoding output.
Patent EP-1224940-B2 (EP)
Inventor: TSCHOEPE MICHAEL
IPC: A61K38/21
Filed: 1998-09-23
Granted: 2010-08-11
Abstract: Stable interferon-beta (I) solution of neutral or slightly acid pH (pH 5-8) is new. Liquid formulations of human (I), that retain at least 80% of in vitro biological activity after storage for 3 months at 25 degrees Centigrade, contain up to 25 MU (units)/ml of (I), are buffered to pH 5-8, preferably over 5.5, and are free of human serum albumin (HSA); are buffered to pH 6-7.2 and are free of HSA, or are buffered to pH 5-8, preferably over 5.5, and contain at least one amino acid.
Patent EP-1444346-B2 (EP)
Inventor: ARTS GERT-JAN
IPC: C12N15/09
Filed: 2002-08-29
Granted: 2015-06-24
Abstract: Isolated polynucleotides, and vectors including the same, are disclosed as useful for down-regulation of specific RNA in cells, including a first sequence of about 17 to about 23 nucleotides, complementary to said RNA, and linked to a second sequence capable of forming a loop when said second sequence is RNA. The polynucleotides include self-complementing single-stranded polynucleotides, including a third sequence linked by said second sequence where all nucleotides in said first and said third sequences are complementary. Functional genomic, diagnostic and therapeutic methods are disclosed that involve reducing the amount of a unique RNA sequence in cells using a vector encoding the self-complementing polynucleotide including a first sequence complementary to said RNA sequence. Methods are also disclosed for preparing the polynucleotides, vectors, libraries of vectors, and the temporary knock-down of proteins, such as lethal proteins, during virus or recombinant protein production.
Patent EP-1591406-B2 (EP)
Inventor: KOVANEN MARKKU
IPC: B66B19/02
Filed: 2005-04-28
Granted: 2016-07-06
Abstract: The invention relates to a method for changing the rope of a traction sheave elevator. In the method, the new rope (1) is fastened as an extension to the old rope (4) threaded over the diverting pulleys (2) and traction sheave (3), and the new rope is pulled by means of the old rope into the place of the old rope. The apparatus comprises relief devices (10) to be mounted on the rim of the traction sheave (3) to keep the rope (1, 4) clear of contact with the rope groove (9) of the traction sheave (3), a joining element (11) for joining the old rope (4) and the new rope (1) together end to end, and a rope pulling device (12) for pulling the ropes (1, 4).
Patent EP-2248841-B2 (EP)
Inventor: MIYAMOTO MASAAKI
IPC: C08G64/30
Filed: 2003-04-10
Granted: 2015-03-11
Abstract: A subject for the invention is to provide a branched aromatic polycarbonate which is excellent in hue and in melt characteristics such as melt strength.  The invention provides an aromatic polycarbonate composition comprising an aromatic polycarbonate and a carbonic diester compound, wherein the aromatic polycarbonate is obtained by the transesterification method and has a viscosity-average molecular weight of 16,000 or higher, the ratio of the weight-average molecular weight (Mw) to the number-average molecular weight (Mn) of the aromatic polycarbonate as measured by gel permeation chromatography and calculated for standard polystyrene (Mw/Mn) is in the range of from 2.8 to 4.5, the content of the carbonic diester compound is 200 ppm by weight or less, and the proportion of the number of moles of all branched structural units to 1 mol of structural units represented by general formula (1), as measured by HPLC after hydrolysis, is higher than 0.3 mol% and not higher than 0.95 mol%:   
(wherein X is a member selected from the group consisting of a single bond, an alkylene group having 1 to 8 carbon atoms, an alkylidene group having 2 to 8 carbon atoms, a cycloalkylene group having 5 to 15 carbon atoms, a cycoalkylidene group having 5 to 15 carbon atoms, and bivalent groups represented by -O-, -S-, -CO-, -SO-, and -SO 2 -).  The invention further provides a hollow container obtained by the blow molding of the aromatic polycarbonate composition.
Patent EP-0016552-B2 (EP)
IPC: C12Q1/00
Filed: 1980-02-25
Granted: 1988-01-13
Abstract: Magneticaly-responsive microspheres having Protein A associated with the outer surfaces thereof are reacted with antibodies selective to the cells, bacteria, or viruses to be separated from a mixed population to attach the antibodies in oriented relation with their Fab arms extending outwardly, and the microspheres are then used in a magnetic separation procedure. The preferred microspheres are prepared from a mixture of albumin, Protein A, and magnetic particles, the microspheres being prepared so that the Protein A is present in the exterior surfaces for antibody binding.
Patent EP-0072949-B2 (EP)
IPC: G09F13/04
Filed: 1982-08-05
Granted: 1989-10-25
Abstract: 1. A signal display with an exciting light source (7) of small dimensions and output, and displayed by means of a plastics luminous body (6) in a plastics frame (2), characterised in that the rear side of the plastics luminous body (6) has a white pigmentation, whose surface increases with the distance from the installed light source (7).
Patent EP-0206626-B2 (EP)
Inventor: MARSHALL BARRY JAMES
IPC: A61K33/24
Filed: 1986-06-10
Granted: 2002-05-22
Abstract: Method for the treatment of human and lower animals having an infectious gastrointestinal disorder, comprising the step of administering from about 50 to about 5000 milligrams of bismuth to said subject, per day, for from 3 to 56 days. Preferred processes also include a step for performing a diagnostic step on the subject for detection of campylobacter-like organism infection of the subject.
Patent EP-0418317-B2 (EP)
Inventor: SKAUGEN BORGEIR
IPC: D21F/
Filed: 1989-05-23
Granted: 1999-05-19
Abstract: A process is disclosed for the restrained drying of a paper web in a dryer section (203) of a paper machine. The process includes the steps of wrapping the web with a felt during passage of the web with the felt around a dryer (200) of the dryer section (203) and thereafter wrapping the web around a portion of a guiding device (204) disposed immediately downstream relative to the dryer (200) so that edge curl of the web is minimized.
Patent JP-H0687868-B2 (JP)
IPC: A61F6/04
Filed: 1987-04-24
Abstract: An element for receiving a condom is proposed, which receives the roll of rolled up condom in an annular hollow profile. The front end of the condom projects out of an annular clearance and is protected against unintentional damage by means of two protective disks. The element greatly facilitates handling and requires no additional packing.
Patent JP-S5734674-B2 (JP)
IPC: A61K31/47
Filed: 1974-09-02
Abstract: A laser diode is provided with a casing that encloses a light-emitting crystal. The casing includes a transparent member through which the light passes. A portion of the diode is positioned within a holder and means is provided for cooling the diode. To reduce condensation of moisture which is present within the holder, upon the transparent member, a sleeve formed of a thermally high conductor material such as copper is placed about the casing with close physical contact therebetween.
Patent JP-2565602-B2 (JP)
IPC: C07C337/08
Filed: 1991-05-07
Granted: 1996-12-18
Abstract: Compounds of the formula I <IMAGE> in which A denotes a direct bond or -(CH2)n-, in which n represents 1, 2 or 3; X represents a -C(=Y)-NR6R7 radical; Y represents NR8, O or S; Z represents NR9, O or S; R1 and R2, independently of one another, denote hydrogen or one or more substituents other than hydrogen; the radicals R3, R4, R6, R8 and R9 independently of one another denote hydrogen or lower alkyl; and R5 and R7 independently of one another represent hydrogen, lower alkyl, hydroxyl, etherified or esterified hydroxyl or unsubstituted or mono- or disubstituted amino; tautomers thereof, and salts thereof. They have useful pharmaceutical properties and are particularly active against tumours. They are prepared in a manner known per se.
Patent JP-H0724552-B2 (JP)
IPC: A23L27/60
Filed: 1991-04-10
Abstract: Compositions, enriched in denatured alpha-lactalbumin are obtained by a process for denaturing these lactalbumins under specific conditions and separating these from the undenatured protein. These compositions can be used as texturising agents in food compositions, especially in those with low fat content.
Patent JP-4064491-B2 (JP)
IPC: H05K7/10
Filed: 1997-04-25
Granted: 2008-03-19
Abstract: A connector for electrically interconnecting a lead of a device to a terminal spaced at a distance from the lead. The apparatus may include a contact engagable by the lead and further engagable by the spaced terminal. An elastomeric element is provided to bias the contact in an original position. As the contact is engaged by the lead, the elastomeric element may deform to permit movement of the contact. It is contemplated that the elastomeric element may be shaped, relative to the contact, to provide at least one spatial relief region between the elastomeric element and the contact. Further, it is contemplated that the elastomeric element may have one or more cavities formed therein to provide at least one spatial relief region. Finally, it is contemplated that the contact housing may be designed to provide at least one spatial relief region adjacent the elastomeric element. Accordingly, as a force to applied to the contact via a lead or the like, the elastomeric element may become deformed, causing a portion of the deformed elastomeric element to extend at least partially into the at least one spatial relief region. It has been found that by providing even a modest spatial relief region adjacent the elastomeric element, the lifetime of the elastomeric element may be substantially increased. <IMAGE>
Patent JP-H0459909-B2 (JP)
IPC: G01F11/08
Filed: 1988-05-19
Abstract: A cassette (18) containing a group of sealed cells is used as a means for delivering doses of fluid to be injected into a sterilizing chamber (10). After the cassette (18) is automatically positioned over a piercing mechanism, the cassette is moved downwardly so that a cell is pierced. Fluid is then forced out of the cell by pneumatic pressure into an injector valve (22), which opens in a manner which does not adversely affect a vacuum within the chamber (10)
Patent JP-S6129950-B2 (JP)
IPC: A61K31/55
Filed: 1982-08-26
Abstract: Compounds corresponding to the general formula:    <IMAGE>  (I)  in which X and Y identical or different, represent a hydrogen or a halogen atom, a lower alkyl, a lower alkoxy or a trifluormethyl group, A represents a methylene group, a direct bond or an imino-NR3- group in which R3 is a hydrogen atom or a lower alkyl or lower alkanoyl group R1 and R2 identical or different, each represents a hydrogen atom or a lower alkyl group, or together with the nitrogen atom to which they are attached they form a pyrrolidino, piperidino or methyl-4 piperazine group, and n represents an integer from 1 to 3, in their racemic or optical isomeric forms, as well as their salts of addition with a therapeutically compatible mineral or organic acid. These compounds are useful as antidepressants.
Patent JP-4224733-B2 (JP)
IPC: C22C38/18
Filed: 1998-05-29
Granted: 2009-02-18
Abstract: Manufacture of less than 10 mm thick strip of ferritic stainless steel (  NOTGREATER  0.012% C,  NOTGREATER  1% Mn,  NOTGREATER 1% Si, NOTGREATER  0.040% P,  NOTGREATER  0.030% S and 16-18% Cr) involves (a) (naturally) cooling twin-roll continuously cast strip without holding in the austenitic transformation region; (b) optionally hot rolling at 900-1150 degrees C with ≥ 5% thickness reduction; (c) coiling at between 600 degrees C and the martensitic transformation temperature (Ms); (d) cooling at  NOTGREATER  300 degrees C/hr. to between 200 degrees C and ambient temperature; and (e) bell annealing, preferably at 800-850 degrees C for ≥ 4 hrs. Preferably, step (a) is carried out by cooling the strip immediately after leaving the casting rolls, at ≥ 10 degrees C/sec. down to 600 degrees C. Also claimed is ferritic stainless steel strip made by the above process.
Patent JP-2888401-B2 (JP)
IPC: G11C29/00
Filed: 1993-06-29
Granted: 1999-05-10
Abstract: A multiprocessor system includes a plurality of substantially identical nodes interconnected through a switching network, each node including a disk drive, NVRAM, and a processor. The system stores data in either a RAID or mirrored fashion across a plurality of disk drives in different nodes. When data is stored in a RAID arrangement, an NVRAM in a parity node is provided with an entry including the new data, a copy of old data from the node to which the new data is to be written, a copy of the old parity, and a synchronization state indicator. The parity node determines new parity and transmits the new data to the data node for storage. Upon receiving an acknowledgement, the parity node resets the synchronization indicator. When power-up occurs, after a power failure, the parity node scans its NVRAM for any entry and upon finding one with a non-reset state indicator, transmits the new data to a destination data node for entry thereby synchronizing the contents of data and parity nodes. In a mirrored system, NVRAM in only one node has a data identifier entered into its NVRAM so that, upon a power failure and subsequent power-up, that entry enables the system to know which disk drives are in a non-synchronized state, and to cause actions that result in re-synchronization.
Patent JP-3285421-B2 (JP)
IPC: A61P43/00
Filed: 1993-07-02
Granted: 2002-05-27
Abstract: Compounds corresponding to the general formula (I) <IMAGE> in which m represents the number 0 or 1, R1 represents a methyl group, in which case R2 represents a phenoxy(C1-C4)alkyl group, or else R1 and R2 together form, and with the nitrogen atom which carries them, a 4-phenoxy-1-piperidyl (4-phenoxypiperidino) group, a phenoxymethyl-1-piperidyl (phenoxymethylpiperidino) group or a 4-phenyl-1-piperazinyl group, and R3 represents a hydrogen atom or, when n is equal to 1, a hydroxyl group or a methoxy group. Application in therapeutics.
Patent JP-H0143761-B2 (JP)
IPC: C08B11/193
Filed: 1981-10-21
Abstract: Disclosed are water-soluble cellulose mixed ethers which contain (a) at least one substituent from the group comprising alkyl, hydroxyalkyl, carboxyalkyl, sulfoalkyl and dialkylaminoalkyl and (b) a phosphonomethyl substituent and which has a DS of the first substituent(s) other than hydroxyalkyl from about 0.05 to 2.95 and/or an MSHAlk from about 0.5 to 6 and a DSPM from about 0.005 to 0.8. Also disclosed is a process for preparing such cellulose mixed ethers in which, per mole of the cellulose, from about 0.1 to 25 moles of the etherifying agent(s) for producing the substituent(s) under (a), from about 0.05 to 2 moles of halogenomethane phosphonate ions as the etherifying agent for producing the substituent under (b) and from about 0.8 to 12 moles of hydroxide ions are caused to react in a reaction mixture comprising up to about 30 parts by weight, per part by weight of the cellulose, of a mixture which is composed of an inert, preferably water-miscible organic solvent and H2O and in which the proportion of water ranges from about 3 to 40 percent by weight.
Patent JP-3093242-B2 (JP)
IPC: C07D521/00
Filed: 1990-06-27
Granted: 2000-10-03
Abstract: The invention relates to a process for reducing the crystal size of ondansetron hydrochloride dihydrate produced by crystallisation from solvent to a size which is suitable for effective distribution in a tablet blend, in particular 100% less that 250 mu m. The ondansetron hydrochloride dihydrate is desolvated by drying at elevated temperature and reduced or atmospheric pressure and is then rehydrated.